Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE)-Reference-Cited by-同舟云学术

Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE)

Published:2014-09 Issue:6 Volume:17 Page:744-748
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Recht Michael,Neufeld Ellis J.,Sharma Vivek R.,Solem Caitlyn T.,Pickard A. Simon,Gut Robert Z.,Cooper David L.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference14 articles.

1. Guidelines for the Management of Hemophilia,2005

2. Efficacy and safety of recombinant factor VIII products in patients with hemophilia A;Musso;Drugs Today,2008

3. CDC Universal Data Collection. Summary Report of UDC Activity. National Treatment/Clinical Characteristics (Hemophilia). 2011.

4. Coagulation Factor VIIa (Recombinant) Room Temperature Stable [prescribing information];NovoSeven,2010

5. (Anti-Inhibitor Coagulant Complex), Nanofiltered and Vapor Heated [package insert];FEIBA,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A;Journal of Thrombosis and Haemostasis;2024-07

3. Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study;Journal of Clinical Medicine;2021-12-18

4. Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol;PLOS ONE;2021-08-26

5. European principles of care for women and girls with inherited bleeding disorders;Haemophilia;2021-08-03